1. Home
  2. MDAIW vs ECCC Comparison

MDAIW vs ECCC Comparison

Compare MDAIW & ECCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • ECCC
  • Stock Information
  • Founded
  • MDAIW N/A
  • ECCC N/A
  • Country
  • MDAIW United States
  • ECCC United States
  • Employees
  • MDAIW 78
  • ECCC N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • ECCC Trusts Except Educational Religious and Charitable
  • Sector
  • MDAIW Health Care
  • ECCC Finance
  • Exchange
  • MDAIW Nasdaq
  • ECCC Nasdaq
  • Market Cap
  • MDAIW N/A
  • ECCC N/A
  • IPO Year
  • MDAIW N/A
  • ECCC N/A
  • Fundamental
  • Price
  • MDAIW $0.70
  • ECCC $24.12
  • Analyst Decision
  • MDAIW
  • ECCC
  • Analyst Count
  • MDAIW 0
  • ECCC 0
  • Target Price
  • MDAIW N/A
  • ECCC N/A
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • ECCC N/A
  • Earning Date
  • MDAIW 02-27-2025
  • ECCC N/A
  • Dividend Yield
  • MDAIW N/A
  • ECCC N/A
  • EPS Growth
  • MDAIW N/A
  • ECCC N/A
  • EPS
  • MDAIW N/A
  • ECCC N/A
  • Revenue
  • MDAIW $27,264,000.00
  • ECCC N/A
  • Revenue This Year
  • MDAIW N/A
  • ECCC N/A
  • Revenue Next Year
  • MDAIW N/A
  • ECCC N/A
  • P/E Ratio
  • MDAIW N/A
  • ECCC N/A
  • Revenue Growth
  • MDAIW 44.52
  • ECCC N/A
  • 52 Week Low
  • MDAIW $0.08
  • ECCC N/A
  • 52 Week High
  • MDAIW $0.90
  • ECCC N/A
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW 48.73
  • ECCC 47.53
  • Support Level
  • MDAIW $0.70
  • ECCC $23.50
  • Resistance Level
  • MDAIW $0.90
  • ECCC $24.70
  • Average True Range (ATR)
  • MDAIW 0.07
  • ECCC 0.33
  • MACD
  • MDAIW 0.00
  • ECCC 0.00
  • Stochastic Oscillator
  • MDAIW 39.39
  • ECCC 15.94

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About ECCC Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031

Eagle Point Credit Co Inc. is an externally managed, non-diversified closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective of capital appreciation. The Company seeks to achieve its investment objectives by investing in equity and junior debt tranches of collateralized loan obligations ("CLOs") collateralized by a portfolio consisting of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. The Company intends to operate so as to qualify to be taxed as a regulated investment company.

Share on Social Networks: